Oxidised LDL and progression of atherosclerosis

Comment

M Strahilevitz. Lancet. 1992.

. 1992 Jul 25;340(8813):235; author reply 236.

No abstract available

Comment on

Autoantibody against oxidised LDL and progression of carotid atherosclerosis.
Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Salonen JT, et al. Lancet. 1992 Apr 11;339(8798):883-7. doi: 10.1016/0140-6736(92)90926-t. Lancet. 1992. PMID: 1348295

Antibodies to oxidised LDL.
Vaarala O. Vaarala O. Lupus. 2000;9(3):202-5. doi: 10.1191/096120300678828280. Lupus. 2000. PMID: 10805488 Review.
Antibodies to oxidised LDL in atherosclerosis.
[No authors listed] [No authors listed] Lancet. 1992 Apr 11;339(8798):899-900. Lancet. 1992. PMID: 1348301 No abstract available.
Autoantibody against oxidised LDL and progression of carotid atherosclerosis.
Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Salonen JT, et al. Lancet. 1992 Apr 11;339(8798):883-7. doi: 10.1016/0140-6736(92)90926-t. Lancet. 1992. PMID: 1348295
Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.
Wu JT, Wu LL. Wu JT, et al. Clin Lab Med. 1997 Sep;17(3):595-604. Clin Lab Med. 1997. PMID: 9316776 Review.
Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?
Shoenfeld Y, Wu R, Dearing LD, Matsuura E. Shoenfeld Y, et al. Circulation. 2004 Oct 26;110(17):2552-8. doi: 10.1161/01.CIR.0000143225.07377.EA. Circulation. 2004. PMID: 15505108 No abstract available.